These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 9606478)
1. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals. Faris MA; Raasch RH; Hopfer RL; Butts JD Ann Pharmacother; 1998 May; 32(5):564-73. PubMed ID: 9606478 [TBL] [Abstract][Full Text] [Related]
2. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment]. Schneider MM; Reiss P; Borleffs JC; Rozenberg-Arska M; Hoepelman IM Ned Tijdschr Geneeskd; 1997 Jan; 141(2):80-3. PubMed ID: 9036351 [TBL] [Abstract][Full Text] [Related]
3. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS. Wright J Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648 [TBL] [Abstract][Full Text] [Related]
4. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis. Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210 [TBL] [Abstract][Full Text] [Related]
5. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. Cohn DL Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program. Phillips P; Chan K; Hogg R; Bessuille E; Black W; Talbot J; O'Shaughnessy M; Montaner J Clin Infect Dis; 2002 Feb; 34(3):371-8. PubMed ID: 11774085 [TBL] [Abstract][Full Text] [Related]
7. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Uthman MM; Uthman OA; Yahaya I Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Karakousis PC; Moore RD; Chaisson RE Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223 [TBL] [Abstract][Full Text] [Related]
9. Controversies in the management of Mycobacterium avium complex infection in AIDS patients. Peloquin CA Ann Pharmacother; 1993; 27(7-8):928-37. PubMed ID: 8364280 [TBL] [Abstract][Full Text] [Related]
10. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease. Dautzenberg B Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871 [TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. Sterling TR; Moore RD; Graham NM; Astemborski J; Vlahov D; Chaisson RE AIDS; 1998 Aug; 12(12):1451-7. PubMed ID: 9727565 [TBL] [Abstract][Full Text] [Related]
13. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease. Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic options for the management and prevention of Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. Tartaglione TA Pharmacotherapy; 1996; 16(2):171-82. PubMed ID: 8820462 [TBL] [Abstract][Full Text] [Related]
15. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated? Lange CG; Woolley IJ; Brodt RH Drugs; 2004; 64(7):679-92. PubMed ID: 15025543 [TBL] [Abstract][Full Text] [Related]
16. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection. Sesin GP; Manzi SF; Pacheco R Am J Health Syst Pharm; 1996 Nov; 53(21):2585-90. PubMed ID: 8913387 [TBL] [Abstract][Full Text] [Related]
17. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS. Gordin F; Masur H Clin Infect Dis; 1994 Apr; 18 Suppl 3():S223-6. PubMed ID: 8204774 [TBL] [Abstract][Full Text] [Related]
18. Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS. Archange YR; Carrey Z; Zanlungo PG J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):20-2. PubMed ID: 11362747 [TBL] [Abstract][Full Text] [Related]
19. The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections. Amsden GW; Peloquin CA; Berning SE Drugs; 1997 Jul; 54(1):69-80. PubMed ID: 9211081 [TBL] [Abstract][Full Text] [Related]
20. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART? Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT; AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]